-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Vor Biopharma, Maintains $31 Price Target

Benzinga·05/18/2026 17:49:58
Listen to the news
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Vor Biopharma (NASDAQ:VOR) with a Buy and maintains $31 price target.